
|Articles|June 8, 2010
- Summer 2010
- Volume 9
- Issue 2
The Us TOO International Summit, Symposium & Celebration
Author(s)Bunmi Ishola
Advertisement
Us TOO invites prostate cancer patients, survivors, and their families to the Chicago area this summer to celebrate its 20th anniversary. The two-day event, “From Passion to Action: Us TOO at 20,” will be held August 20—21, and kicks off with an advocacy summit about the prostate cancer screening debate. Participants will have the opportunity to attend the educational sessions on treatments, lifestyle and diet choices, updates on research, and more. For more information, visit
Articles in this issue
over 16 years ago
Integrative Medicine: Exercise Scores Against Anxietyover 16 years ago
Web Exclusive: Find a Clinical Trial That's Right for Youover 16 years ago
Web Exclusive: Standing Up to Cancerover 16 years ago
Web Exclusive: An Excerpt from "Conquer Prostate Cancer"over 16 years ago
More Therapies Needed for Childhood Cancersover 16 years ago
Pipelineover 16 years ago
The Price of Parenthoodover 16 years ago
What Is Metastatic Cancer?over 16 years ago
Teaming Up Against Liver CancersAdvertisement
Related to this article

See how FDA-approved lymphoma treatments have changed over 5 years — what's new, who it's helped, and what's still to come.

Kazia Therapeutics CEO Dr. John Friend discussed how paxalisib is being studied in HR-positive, HER2-negative breast cancer, why researchers are focusing on treatment resistance and what the ongoing clinical trial could show for patients.

An expert discusses August's FDA approvals for myeloma, polycythemia vera and essential thrombocythemia, plus first-line myeloma care and MRD testing.

Patients with colorectal cancer who walked more had less fatigue and better quality of life, regardless of how active they were at diagnosis.

CURE spoke with Oncology Aesthetics & Wellness founder, Deborah A. McDowell, about hair preservation before, during and after cancer treatment.

A genomic test led physicians to change extended endocrine therapy recommendations for 42% of people with early-stage HR-positive breast cancer.

A wife reflects on her husband’s cancer treatment, finding comfort, hope and connection in their simple ritual of sharing bagels before each treatment.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Welireg Plus Lenvima for Advanced Kidney Cancer After Immunotherapy
2
How Paxalisib Targets Treatment Resistance in Breast Cancer
3
7 Breast Cancer Clinical Trials Currently Enrolling in the US
4
What to Do Before Your Chemo Infusion: A Checklist From People Who've Been There
5

